RTOG Foundation Study 3502
Status Date: January 03, 2020 | Status: Closed to Accrual
A Randomized Phase II Trial In Patients With Operable Stage I Non-Small Cell Lung Cancer: Radical Resection Versus Ablative Stereotactic Radiotherapy
China: Jinming Yu, MD, PhD
U.S.: Feng-Ming (Spring) Kong, MD, PhD
To determine whether SBRT provides local-regional tumor control that is not more than 15% lower than RODS.
Patients must have histologically proven CT and PET-CT confirmed Stage I, T1N0M0 non-small cell lung cancer.
|Chinese Academy of Medical Sciences||Beijing||China|
|Shandong Cancer Hospital||Jinan||Shandong, China|
|Shanghai Cancer Center/Fudan University||Shanghai||China|
|Zhejiang Cancer Hospital||Hangzhou||Zhejiang, China|